Adoption of NGS Reflex Testing for Lung Cancer Efficient, Cost Effective, Study Finds

Click here to view original web page at

NEW YORK (GenomeWeb) – Pathologists at University Hospitals Cleveland Medical Center have reported an in-house next-generation sequencing assay for advanced lung cancer reflex testing to be as reliable, cost-effective, and efficient as single-gene testing while providing additional benefits.

Only $95 for the first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

You may already have institutional access!

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Related posts

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.